Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bastide Le Confort MedicalLTS:0IP1 70 Equity-to-Asset is 0.18 as of Dec. 2025, which is 20% above its 10-year median of 0.15. GuruFocus rates LTS:0IP1 with a GF Score™ of 70/100 and a GF Value™ of €26.02 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 120 Medical Distribution companies, Bastide Le Confort Medical ranks worse than 85% on this metric.
Bastide Le Confort Medical (LTS:0IP1) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Bastide Le Confort Medical Equity-to-Asset Related Terms
Bastide Le Confort Medical Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0IP1 vs MCK, COR, CAH: Equity-to-Asset Comparison
For the Medical Distribution subindustry, Bastide Le Confort Medical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bastide Le Confort Medical Equity-to-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Bastide Le Confort Medical's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Bastide Le Confort Medical's Equity-to-Asset falls into.
Bastide Le Confort Medical Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Bastide Le Confort Medical's Equity to Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bastide Le Confort Medical (LTS:0IP1) has a Equity-to-Asset of 0.18 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bastide Le Confort Medical and its competitors. This is 20% above median its historical median of 0.15. Over the past decade, Bastide Le Confort Medical's Equity-to-Asset has ranged from 0.11 to 0.31. According to the industry distribution chart, Bastide Le Confort Medical ranks #102 out of 120 companies in the Medical Distribution industry, placing it in the top 85%.
Is Bastide Le Confort Medical's Equity-to-Asset too high?
Bastide Le Confort Medical's current Equity-to-Asset of 0.18 is 20% above median its 10-year median of 0.15. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 0.31. The Medical Distribution industry median Equity-to-Asset is 0.39. Bastide Le Confort Medical's value of 0.18 is 53.8% below this industry median. Based on the distribution chart, Bastide Le Confort Medical ranks #102 out of 120 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Bastide Le Confort Medical has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's Equity-to-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Bastide Le Confort Medical ranks #102 out of 120 companies for Equity-to-Asset. This places Bastide Le Confort Medical in the lower half of its industry. The industry median Equity-to-Asset is 0.39. Bastide Le Confort Medical's value of 0.18 is 53.8% below this benchmark. Historically, Bastide Le Confort Medical's own Equity-to-Asset has ranged from 0.11 to 0.31 over the past decade. While the company's 10-year median is 0.15 vs. the industry median of 0.39, Bastide Le Confort Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Distribution company?
The median Equity-to-Asset among Medical Distribution companies is 0.39, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bastide Le Confort Medical's current Equity-to-Asset of 0.18 is 53.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bastide Le Confort Medical and its competitors. For the Medical Distribution industry, the median Equity-to-Asset is 0.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bastide Le Confort Medical's current Equity-to-Asset is 0.18, which is 20% above median its own 10-year median of 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (LTS:0IP1) is currently considered Modestly Undervalued. The stock's GF Value™ is €26.02, compared to a current price of €22.50 — trading 13.5% below its estimated fair value. The current Equity-to-Asset is 0.18, which is 20% above median its 10-year median of 0.15 and 53.8% below the Medical Distribution industry median of 0.39. Bastide Le Confort Medical's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Bastide Le Confort Medical (LTS:0IP1), the current Equity-to-Asset is 0.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bastide Le Confort Medical (LTS:0IP1) Overvalued in 2026?
Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued.
The current stock price of €22.50 is trading 13.5% below its estimated GF Value™ of €26.02.
GuruFocus considers Bastide Le Confort Medical to be Modestly Undervalued.
Key valuation signals for LTS:0IP1:
Equity-to-Asset: 0.18 (20% above median its 10-year median of 0.15)
GF Value™: €26.02 vs. price of €22.50 (13.5% below fair value)
Industry Position: 53.8% below the Medical Distribution median (#102 of 120)
No single metric tells the full story. See the LTS:0IP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
70GF Score
Get the complete analysis for LTS:0IP1
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0IP1 has been successfully added to your 
